BECTON DICKINSON & CO - 10-Q Filing

Becton Dickinson & Co filed a Form 10-Q for the quarter ended March 31, 2026. The filing includes financial data and disclosures related to operating segments such as Medication Delivery Solutions, Medical Essentials, Specimen Management, Connected Care, and BioPharma Systems.

SEC EDGAR ·

Tickers: $BDX

Read the full article at SEC EDGAR

More Regulatory news